Proteomic investigation of intra-tumor heterogeneity using network-based contextualization - A case study on prostate cancer

J Proteomics. 2019 Aug 30:206:103446. doi: 10.1016/j.jprot.2019.103446. Epub 2019 Jul 16.

Abstract

Cancer is a heterogeneous disease, confounding the identification of relevant markers and drug targets. Network-based analysis is robust against noise, potentially offering a promising approach towards biomarker identification. We describe here the application of two network-based methods, qPSP (Quantitative Proteomics Signature Profiling) and PFSNet (Paired Fuzzy SubNetworks), in an intra-tissue proteome data set of prostate tissue samples. Despite high basal variation, we find that traditional statistical analysis may exaggerate the extent of heterogeneity. We also report that network-based analysis outperforms protein-based feature selection with concomitantly higher cross-validation accuracy. Overall, network-based analysis provides emergent signal that boosts sensitivity while retaining good precision. It is a potential means of circumventing heterogeneity for stable biomarker discovery.

Keywords: Bioinformatics; Biomarker; Networks; Proteomics; Systems biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / metabolism
  • Computational Biology
  • Gene Regulatory Networks / physiology
  • Genetic Heterogeneity
  • Humans
  • Male
  • Neoplasm Proteins / analysis
  • Neoplasm Proteins / metabolism*
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology*
  • Protein Binding
  • Protein Interaction Maps* / physiology
  • Proteome / analysis
  • Proteome / metabolism*
  • Proteomics / methods
  • Signal Transduction / physiology
  • Systems Biology

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Proteome